COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 249: Articles 2481-2490  | Next

Distinct SARS-CoV-2 populational immune backgrounds induce divergent RBD evolutionary preferences
Ma, W., Fu, H., Jian, F., Cao, Y. R., Li, M.
10.1101/2023.12.19.572469 — Posted: 2023-12-20
Deep profiling of antigen-specific B cells from different pathogens identifies novel compartments in the IgG memory B cell and antibody-secreting cell lineages
Claireaux, M., Elias, G., Kerster, G., Kuijper, L. H., Duurland, M. C., Paul, A. G., Burger, J. A., Poniman, M., Olijhoek, W., de Jong, N., de Jongh, R., Wynberg, E., van Willigen, H. D., Prins, M., de Bree, G. J., de Jong, M. D., Kuijpers, T. W., Eftimov, F., van der Schoot, C. E., Rispens, T., Garcia-Vallejo, J. J., ten Brinke, A., van Gils, M. J., van Ham, S. M.
10.1101/2023.12.19.572339 — Posted: 2023-12-20
Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19
Lee, J. T. H., Barnett, S. N., Roberts, K., Ashwin, H., Milross, L., Cho, J.-W., Huseynov, A., Woodhams, B., Aivazidis, A., Li, T., Majo, J., Guerrero, P. C., Lee, M., Miranda, A. M. A., Jablonska, Z., Arena, V., Hanley, B., Osborn, M., Uhlmann, V., Xu, X.-N., McLean, G. R., Teichmann, S. A., Randi, A. M., Filby, A., Kaye, P. M., Fisher, A. J., Hemberg, M., Noseda, M., Bayraktar, O. A.
10.1101/2023.12.20.572494 — Posted: 2023-12-20
Cell type-specific adaptation of the SARS-CoV-2 spike
Carrascosa-Saez, M., Marques, M.-C., The IBV-COVID19-Pipeline, , Geller, R., Elena, S. F., Rahmeh, A., Dufloo, J., Sanjuan, R.
10.1101/2023.12.20.572504 — Posted: 2023-12-20
Temperature impacts SARS-CoV-2 spike fusogenicity and evolution
Dufloo, J., Sanjuan, R.
10.1101/2023.12.20.572501 — Posted: 2023-12-20
Inverse folding of protein complexes with a structure-informed language model enables unsupervised antibody evolution
Shanker, V. R., Bruun, T. U. J., Hie, B. L., Kim, P. S.
10.1101/2023.12.19.572475 — Posted: 2023-12-20
Predicting the Trend of SARS-CoV-2 Mutation Frequencies Using Historical Data
zhou, x., Hu, K., Pan, M., Zhang, C., Cao, S.
10.1101/2023.12.19.572480 — Posted: 2023-12-20
Clinical, laboratory, and imaging findings of stage 3-5 chronic kidney disease patients suffering from COVID-19 in Bangladesh: a prospective cross-sectional study
Ullah, A., Khanam, A., Mondal, M., Haque, M. R., Sumon, A. S. H., Khan, S., Haque, M. M., Sumon, M. R., Rahman, M. M.
10.1101/2023.12.18.23300150 — Posted: 2023-12-19
The magnitude and cross reactivity of SARS-CoV-2 specific antibody responses in vaccinated and unvaccinated Sri Lankan children and association with nutrition status
Jeewandara, C., Karunananda, M. V., Fernando, S., Danasekara, S., Jayakody, G., Arulkumaran, S., Samaraweera, N. Y., Kumarawansha, S., Sivaganesh, S., Amarasinghe, P. G., Jayasinghe, C., Wijesekara, D., Marasinghe, M. B., Mambulage, U., Wijayatilaka, H., Seneviratne, K., Bandara, A. D. P., Gallage, C. P., Colambage, N. R., Udayasiri, T. T., Lokumarambage, T., Upasena, Y., Weerasooriya, W. P. K. P., Seroprevalence Study Group, , Tang, T. K., Townsend, A., Ogg, G. S., Malavige, G. N.
10.1101/2023.12.18.23300176 — Posted: 2023-12-19
Covid-19 Risk by work-related factors: Pooled analysis of individual linked data from 14 cohorts
Gittins, M., Rhodes, S., Wels, J., Wielgoszewska, B., Zhu, J., Shaw, R. J., Hamilton, O. K., Demou, E., Stevenson, A. J., Rhead, R., Katikireddi, S. V., Ploubidis, G. B., van Tongeren, M.
10.1101/2023.12.19.23298502 — Posted: 2023-12-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).